ZS Pharma (ZSPH) Posts Q3 Loss of 41c/Share

ZS Pharma (Nasdaq: ZSPH) reported Q3 EPS of ($0.41), $0.63 better than the analyst estimate of ($1.04).

The company reported a loss of $0.81 per share in the same period last year.

For earnings history and earnings-related data on ZS Pharma (ZSPH) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
• Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c